Discontinuation of denosumab in men with prostate cancer

被引：0
|
作者：
Anne Sophie Sølling
Torben Harsløf
Helle Kongsbak Brockstedt
Bente Langdahl
机构：
[1] Aarhus University Hospital,Department of Endocrinology and Internal Medicine
[2] Silkeborg Regional Hospital,Department of Internal Medicine
来源：
Osteoporosis International | 2023年 / 34卷
关键词：
Bone mineral density; Denosumab; Osteoporosis; Prostate cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：291 / 297
页数：6
相关论文
共 50 条
  • [21] Clinical experience with denosumab discontinuation
    Laursen, Natasha
    Solling, Anne Sophie
    Harslof, Torben
    Langdahl, Bente
    OSTEOPOROSIS INTERNATIONAL, 2025, 36 (03) : 435 - 446
  • [22] Denosumab in castration-resistant prostate cancer
    Kyrgidis, Athanassios
    Tzellos, Thrasivoulos-George
    LANCET, 2012, 379 (9828): : E50 - E50
  • [23] Denosumab delays metastasis in prostate cancer patients
    Fricker, Janet
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2011, 72 (11) : 611 - 611
  • [24] Use of denosumab in castration sensitive prostate cancer
    Laurent, Michael R.
    BMJ-BRITISH MEDICAL JOURNAL, 2023, 383
  • [25] Denosumab in men with nonmetastatic castration-resistant prostate cancer (CRPC) at high risk for bone metastases
    Smith, M. R.
    Fizazi, K.
    Miller, K.
    Egerdie, B.
    Morote, J.
    Tammela, T. L.
    Wong, S.
    Ye, Z.
    Braun, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S682 - S682
  • [26] Bone mass following discontinuation of alendronate in men with prostate cancer on androgen deprivation therapy.
    Greenspan, S. L.
    Wagner, J. M.
    Miller, M. E.
    Resnick, N. M.
    Nelson, J. B.
    Trump, D. L.
    Parker, R. A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S219 - S219
  • [27] Influence of physical activity on active surveillance discontinuation in men with low-risk prostate cancer
    Papadopoulos, Efthymios
    Alibhai, Shabbir M. H.
    Tomlinson, George A.
    Matthew, Andrew G.
    Nesbitt, Michael
    Finelli, Antonio
    Trachtenberg, John
    Santa Mina, Daniel
    CANCER CAUSES & CONTROL, 2019, 30 (09) : 1009 - 1012
  • [28] Influence of physical activity on active surveillance discontinuation in men with low-risk prostate cancer
    Efthymios Papadopoulos
    Shabbir M. H. Alibhai
    George A. Tomlinson
    Andrew G. Matthew
    Michael Nesbitt
    Antonio Finelli
    John Trachtenberg
    Daniel Santa Mina
    Cancer Causes & Control, 2019, 30 : 1009 - 1012
  • [29] Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer COMMENT
    Singer, Frederick R.
    JOURNAL OF UROLOGY, 2009, 182 (06): : 2676 - 2676
  • [30] Prostate-specific antigen velocity based risk-adapted discontinuation of prostate cancer screening in elderly men
    Tang, Ping
    Sun, Leon
    Uhlman, Matthew A.
    Robertson, Cary N.
    Polascik, Thomas J.
    Moul, Judd W.
    BJU INTERNATIONAL, 2011, 108 (01) : 44 - 48
12345